Abstract:Introduction: Restoring immune tolerance is a promising area of therapy for autoimmune diseases. One method that helps restore immunological tolerance is the approach using tolerogenic dendritic cells (tolDCs). In our study, we analyzed the effectiveness of using dendritic cells transfected with DNA constructs encoding IL-10, type II collagen, and CCR9 to induce immune tolerance in an experimental model of arthritis. Methods: Dendritic cell cultures were obtained from bone marrow cells of Balb/c mice. Dendritic cells (DCs) cultures were transfected with pmaxCCR9, pmaxIL-10, and pmaxCollagen type II by electroporation. The phenotype and functions of DCs were studied using enzyme-linked immunosorbent assay (ELISA) and flow cytometry. Migration of electroporated DCs was assessed in vitro. Induction of antigen-collagen induced arthritis (ACIA) was carried out according to the protocol in Balb/c mice. DCs were then administered to ACIA mice. The development of arthritis was monitored by measuring paw swelling with a caliper at different time points. The immunological changes were assessed by analyzing the content of antibodies to type II collagen using enzyme immunoassay. Additionally, a histological examination of the joint tissue was conducted, followed by data analysis. The results are as follows: DCs were obtained, characterized by reduced expression of CD80, CD86, and H-2Db (MHC class I), increased expression of CCR9, as well as producing IL-10 and having migratory activity to thymus cells. Transfected DCs induced T-regulatory cells (T-reg) and increased the intracellular content of IL-10 and TGF-β in CD4+T cells in their co-culture, and also suppressed their proliferative activity in response to antigen. The administration of tolDCs transfected with DNA constructs encoding type II collagen, IL-10, and CCR9 to mice with ACIA demonstrated a reduction in paw swelling, a reduction in the level of antibodies to type II collagen, and a regression of histological changes. Conclusion: The study presents an approach by which DCs transfected with DNA constructs encoding epitopes of type II collagen, IL-10 and CCR9 promote the development of antigen-specific tolerance, control inflammation and reduce the severity of experimental arthritis through the studied mechanisms: induction of T-reg, IL-10, TGF-β.

Targeting of the hNC16A collagen domain to dendritic cells induces tolerance to human type XVII collagen

Dendritic cells transfected with DNA constructs encoding CCR9, IL-10, and type II collagen demonstrate induction of immunological tolerance in an arthritis model

Reversal Of Tolerance Induced By Transplantation Of Skin Expressing The Immunodominant T Cell Epitope Of Rat Type Ii Collagen Entitles Development Of Collagen-Induced Arthritis But Not Graft Rejection

Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.

Collagen Epitope Expression on B Cells is Sufficient to Confer Tolerance to Collagen-Induced Arthritis

Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.

T Cell Responses to a Non-Glycosylated Epitope Predominate in Type II Collagen-Immunised HLA-DRB1*0101 Transgenic Mice

Predominant Selection of T Cells Specific for the Glycosylated Collagen Type II Epitope (263-270) in Humanized Transgenic Mice and in Rheumatoid Arthritis.

Glycosylation Of Type Ii Collagen Is Of Major Importance For T Cell Tolerance And Pathology In Collagen-Induced Arthritis

The Impact of Glycosylation on Hla-Dr1-Restricted T Cell Recognition of Type Ii Collagen in A Mouse Model

Intrinsic Tolerance in Autologous Collagen-Induced Arthritis is Generated by CD152-Dependent CD4+ Suppressor Cells

Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis

Absence of NC14A domain of collagen XVII/BP180 in mice results in IL-17-associated skin inflammation.

Inhibition of Macropinocytosis Blocks Antigen Presentation of Type II Collagen in Vitro and in Vivo in HLA-DR1 Transgenic Mice

Substitution of Glutamic Acid at Position 71 of DRβ1*04:01 Induces Collagen‐Specific Tolerance Without Inducing Alloreactivity

Type II Collagen in Cartilage Evokes Peptide-Specific Tolerance and Skews the Immune Response.

Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.

Antigen-Specific Gene Therapy after Immunisation Reduces the Severity of Collagen-Induced Arthritis

T Cells That Are Naturally Tolerant to Cartilage-Derived Type II Collagen Are Involved in the Development of Collagen-Induced Arthritis

T Cells Recognize A Glycopeptide Derived from Type Ii Collagen in A Model for Rheumatoid Arthritis

Systemic Versus Cartilage-Specific Expression Of A Type Ii Collagen-Specific T-Cell Epitope Determines The Level Of Tolerance And Susceptibility To Arthritis